Deep Health AI India Limited (formerly known as Deep Diamond India Limited) has successfully completed the relocation of its registered office from Maharashtra to Rajasthan, marking a significant administrative milestone for the pharmaceutical and healthcare company.

Regulatory Compliance and Notification

The company formally notified BSE Limited on April 14, 2026, regarding the completion of its registered office relocation in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Narayan Singh Rathore signed the official communication, confirming all regulatory requirements had been fulfilled.

Office Relocation Details

The registered office has been shifted from its previous location at "309, 3rd Floor, V Star Plaza Plot No. 16 Chandavarkar Road, Opp. Saraswat Bank, Opposite Raj Mahal Hotel, Borivali West, Maharashtra, India, 400092" to the new address at "506-509, 5th Floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan-313001."

Regulatory Approvals and Documentation

The Ministry of Corporate Affairs issued the Certificate of Registration of Regional Director's Order for change of State on March 26, 2026. This certificate was signed by Atma Sah, serving as Assistant Registrar of Companies/Deputy Registrar of Companies/Registrar of Companies at ROC Jaipur. The interstate relocation required approval from the Regional Director (Western Region), which was granted through an order dated February 09, 2026.

Corporate Identity Updates

Following the successful relocation, the company's Corporate Identity Number (CIN) has been updated to L24100RJ1994PLC112895, reflecting the change in state jurisdiction from Maharashtra (MH) to Rajasthan (RJ). The company continues to operate under its current name, Deep Health AI India Limited, having previously been known as Deep Diamond India Limited.

Shareholder Approval Process

The registered office relocation was initially approved through a special resolution passed by shareholders in the Annual General Meeting held on September 27, 2024. The Memorandum of Association was subsequently amended to reflect the change in registered office clause, with the Regional Director's confirmation received on February 09, 2026.

Business Operations and Focus

According to the company's Memorandum of Association, Deep Health AI India Limited operates in the pharmaceutical and healthcare sector, focusing on manufacturing, marketing, and distribution of drugs, pharmaceuticals, and medical products. The company's business activities include research and development in biotechnology, biochemical processes, and various pharmaceutical formulations including tablets, capsules, and medical equipment.

Deep Health AI India Limited (formerly Deep Diamond India Limited) has submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2026. The certificate was filed with the Bombay Stock Exchange Limited on April 13, 2026.

Regulatory Compliance Certificate

The company confirmed compliance with dematerialization and rematerialization processes through its registrar and transfer agent, MUFG Intime India Pvt Ltd. The certificate addresses key regulatory requirements for securities handling during the specified period.

Company Information

Deep Health AI India Limited operates from its registered office at 506-509 Fifth floor, Apeksha, plot no. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan. The company trades on BSE under scrip code 539559.

RTA Confirmation

MUFG Intime India Private Limited, serving as the company's registrar and transfer agent, provided confirmation on April 1, 2026. The RTA certified that:

• Securities received from depository participants for dematerialization during Q4FY26 were properly confirmed
• All security certificates were listed on relevant stock exchanges
• Physical certificates were mutilated and cancelled after verification
• Depository names were substituted in the member register within prescribed timelines

Regulatory Framework

The certificate submission fulfills mandatory requirements under SEBI (Depositories and Participants) Regulations, 2018. This regulation ensures proper oversight of dematerialization processes and maintains transparency in securities handling by listed companies.

The document was signed by Managing Director Narayan Singh Rathore and copies were provided to National Securities Depository Limited and Central Depository Services (India) Limited, completing the regulatory filing process for Q4FY26.